(redirected from Lymphoproliferative disorders)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
References in periodicals archive ?
In contrast, in chronic lymphoproliferative disorders the existence of more than one pathological cell population, although being much less frequent, is usually associated with the presence of more than one cell clone as demonstrated by molecular studies (129).
Primary cutaneous CD30-positive T-cell lymphoproliferative disorders.
In addition to morphology, immunohistochemistry contributed to the identification of the lymphoproliferative disorders in the specimens (Figure 1, A through F).
Because the irregularity of cell membranes may be observed in other lymphoproliferative disorders or may result from artifact, the application of the tartrate-resistant acid phosphatase (TRAP) stain in HCL has a critical role.
The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
The urine immunofixation test is performed to evaluate the presence of Bence Jones proteinuria (monoclonal free light chains in urine) in patients with multiple myeloma or other lymphoproliferative disorders.
PBL is a distinct disease entity within the spectrum of EBV-associated B-cell lymphoproliferative disorders.
Chapter 30 T-cell lymphoproliferative disorders (Estella Matutes).
IgM paraproteinemia is seen in Waldenstrom macroglobulinemia, B-cell lymphoma or lymphoproliferative disorders, monoclonal gammopathy of undermined significance (MGUS), [mu]-heavy chain disease, and IgM myeloma.
Clinical and pathological prognostic markers for survival in adult patients with post-transplant lymphoproliferative disorders in solid transplant.
They discusses the rare coagulation disorders, autologous stem cell transplantation for multiple myeloma and hematological malignancies, the evidence-based management of fever in the neutropenic patient, Fanconi anemia, low-risk myelodysplastic syndrome, antiphospholipid syndrome, chronic lymphoproliferative disorders, aspirin resistance, hemovigilance, targeted therapy for cancer, thalassemia screening and control, bleeding in dengue virus, aplastic anemia, and leukemia, among other topics.